ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 125 filers reported holding ARRAY BIOPHARMA INC in Q2 2013. The put-call ratio across all filers is 1.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $12,055,000 | +6416.2% | 260,196 | +1697.6% | 0.09% | +8700.0% |
Q4 2017 | $185,000 | -92.3% | 14,475 | -95.0% | 0.00% | -93.8% |
Q2 2017 | $2,406,000 | +11.2% | 287,449 | +18.8% | 0.02% | -5.9% |
Q1 2017 | $2,164,000 | +525.4% | 242,012 | +372.5% | 0.02% | +750.0% |
Q3 2016 | $346,000 | +686.4% | 51,220 | +389.0% | 0.00% | – |
Q4 2015 | $44,000 | -82.5% | 10,475 | -79.0% | 0.00% | -100.0% |
Q4 2013 | $251,000 | -45.0% | 50,000 | -50.2% | 0.00% | -60.0% |
Q2 2013 | $456,000 | – | 100,387 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 16,459,128 | $234,543,000 | 9.43% |
APIS CAPITAL ADVISORS, LLC | 490,000 | $6,983,000 | 9.36% |
BVF INC/IL | 4,744,062 | $67,603,000 | 8.84% |
First Light Asset Management, LLC | 2,853,826 | $40,667,000 | 6.48% |
SECTORAL ASSET MANAGEMENT INC | 2,165,767 | $30,862,000 | 4.20% |
GREAT POINT PARTNERS LLC | 1,850,000 | $26,363,000 | 3.33% |
PACIFIC VIEW ASSET MANAGEMENT, LLC | 146,952 | $2,092,000 | 2.46% |
Birchview Capital, LP | 168,000 | $2,394,000 | 2.26% |
X-Square Capital, LLC | 180,554 | $2,572,000 | 2.02% |
FINANCIAL & INVESTMENT MANAGEMENT GROUP LTD | 295,610 | $4,212,000 | 1.54% |